Cassie Jung's most recent trade in Aquestive Therapeutics Inc was a trade of 80,000 Common Stock done . Disclosure was reported to the exchange on March 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 80,000 | 313,066 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 40,000 | 40,000 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 7,997 | 297,708 (0%) | 0% | 2.6 | 21,192 | Common Stock |
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.65 per share. | 07 Mar 2025 | 7,361 | 305,705 (0%) | 0% | 2.7 | 19,507 | Common Stock |
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.54 per share. | 07 Mar 2025 | 2,182 | 295,526 (0%) | 0% | 2.5 | 5,542 | Common Stock |
| Aquestive Therapeutics Inc | Cassie Jung | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 26 Nov 2024 | 44 | 0 (0%) | 0% | 4.9 | 214 | Common Stock |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 14,120 | 233,066 (0%) | 0% | 4.9 | 68,906 | Common Stock |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 8,300 | 238,886 (0%) | 0% | 4.9 | 40,504 | Common Stock |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.88 per share. | 09 Mar 2024 | 1,132 | 237,754 (0%) | 0% | 4.9 | 5,524 | Common Stock |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 55,000 | 55,000 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 55,000 | 55,000 | - | - | Performance Stock Units | |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 101,250 | 247,186 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2023 | 50,625 | 50,625 | - | - | Non-Qualified Stock Option (right to buy) | |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 10 Mar 2023 | 1,365 | 145,936 (0%) | 0% | 0 | Common Stock | |
| Aquestive Therapeutics Inc | Cassie Jung | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 110,000 | 146,747 (0%) | 0% | 0 | Common Stock |